| answer text |
<p>In the United Kingdom, there are currently arrangements in place for unlicensed
medicines to be provided that are either manufactured in the UK or imported into the
UK under a notification scheme. The national provisions are set out in the Human Medicines
Regulations 2012 (Statutory Instrument 2012/1916). Sponsor companies may set up compassionate
use programmes under the direction of a prescribing physician for specific patients.</p><p>Where
an unmet need has been identified, the Early Access to Medicines Scheme run by the
Medicines and Healthcare products Regulatory Agency also provides opportunity for
supply of medicines awaiting a licence. These are to be prescribed under the responsibility
of the treating physician, supported by a published scientific opinion that has been
considered by the Commission on Human Medicines.</p>
|
 |
